	Xcelience, a contract development and manufacturing organization, announced on July 31, 2015 that it has made a structured cash investment in Powdersize, a Pennsylvania-based company specializing in milling, micronization and powder-size classification for the pharmaceutical industry. This investment was made to grow Powdersize’s business and add particle-size control solutions to Xcelience’s capabilities, the company reported in a press statement.

	Reducing particle size through micronization is considered the leading technology for increasing the bioavailability of oral dosage forms when the API has solubility issues. Current industry trends increasingly demand micronization of APIs with particle sizes of 1-10µm, Xcelience reports.

	Powdersize will continue with expansion plans in a recently added facility, to support the additional business expected with the integration and shared development projects.

Development

Formulation

Outsourcing

PharmTech News

Supplier News

PTSM: Pharmaceutical Technology Sourcing and Management-08-05-2015

Investment in Powdersize adds particle-size control solutions to Xcelience’s capabilities.